Previous studies indicated that PCA-1/ALKBH3 silencing reduces VEGF expression in human pancreatic cancer and that PCA-1/ALKBH3 downregulation significantly decreases the number of microvessels in tumors [101] (Fig. 2). The gene discussed is ALKBH3; the disease is pancreatic neoplasm.